Moderna shares soar on melanoma drug trial success
Go back to Moderna shares soar on melanoma drug trial success| Merck & Co. (NYSE: MRK) | Delayed: 148.35 -1.19 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.54 | 52 Week High | $65.46 | |||
| Open | $146.72 | 52 Week Low | $47.97 | |||
| Day High | $149.01 | P/E | 100.92 | |||
| Day Low | $145.75 | EPS | $1.47 | |||
| Volume | 8,067,765 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 137.99 -4.78 (3.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.77 | 52 Week High | $0.52 | |||
| Open | $137.19 | 52 Week Low | $0.08 | |||
| Day High | $138.80 | P/E | N/A | |||
| Day Low | $133.33 | EPS | $-3.80 | |||
| Volume | 26,249,407 | |||||
